WallStreetZenWallStreetZen

NASDAQ: RCKT
Rocket Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for RCKT

Based on 6 analysts offering 12 month price targets for Rocket Pharmaceuticals Inc.
Min Forecast
$39.00+72.41%
Avg Forecast
$54.33+140.2%
Max Forecast
$65.00+187.36%

Should I buy or sell RCKT stock?

Based on 6 analysts offering ratings for Rocket Pharmaceuticals Inc.
Strong Buy
Strong Buy
4 analysts 66.67%
Buy
1 analysts 16.67%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RCKT stock forecasts and price targets.

RCKT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-07
lockedlocked$00.00+00.00%2024-04-02
lockedlocked$00.00+00.00%2024-03-01
lockedlocked$00.00+00.00%2024-02-27
lockedlocked$00.00+00.00%2024-02-27
Cantor Fitzgerald
Top 7%
94
Strong BuyReiterates$65.00+187.36%2024-01-31

1 of 1

Forecast return on equity

Is RCKT forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.27%

Forecast return on assets

Is RCKT forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

RCKT revenue forecast

What is RCKT's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$26.0M
Avg 2 year Forecast
$191.6M
Avg 3 year Forecast
$482.2M

RCKT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RCKT$22.62$54.33+140.20%Strong Buy
BEAM$24.62$41.00+66.53%Buy
CGON$29.98$63.75+112.64%Strong Buy
ADMA$9.21$10.50+14.01%Strong Buy
KYMR$34.95$45.71+30.80%Strong Buy
View Top Biotech Stocks

Rocket Pharmaceuticals Stock Forecast FAQ

Is Rocket Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: RCKT) stock is to Strong Buy RCKT stock.

Out of 6 analysts, 4 (66.67%) are recommending RCKT as a Strong Buy, 1 (16.67%) are recommending RCKT as a Buy, 1 (16.67%) are recommending RCKT as a Hold, 0 (0%) are recommending RCKT as a Sell, and 0 (0%) are recommending RCKT as a Strong Sell.

If you're new to stock investing, here's how to buy Rocket Pharmaceuticals stock.

What is RCKT's revenue growth forecast for 2024-2026?

(NASDAQ: RCKT) Rocket Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.

Rocket Pharmaceuticals's revenue in 2024 is $0.On average, 5 Wall Street analysts forecast RCKT's revenue for 2024 to be $2,363,605,646, with the lowest RCKT revenue forecast at $72,625,769, and the highest RCKT revenue forecast at $9,023,751,773. On average, 5 Wall Street analysts forecast RCKT's revenue for 2025 to be $17,392,873,023, with the lowest RCKT revenue forecast at $2,097,069,074, and the highest RCKT revenue forecast at $29,576,844,344.

In 2026, RCKT is forecast to generate $43,777,724,046 in revenue, with the lowest revenue forecast at $23,478,095,409 and the highest revenue forecast at $64,077,352,683.

What is RCKT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: RCKT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is RCKT's Price Target?

According to 6 Wall Street analysts that have issued a 1 year RCKT price target, the average RCKT price target is $54.33, with the highest RCKT stock price forecast at $65.00 and the lowest RCKT stock price forecast at $39.00.

On average, Wall Street analysts predict that Rocket Pharmaceuticals's share price could reach $54.33 by May 7, 2025. The average Rocket Pharmaceuticals stock price prediction forecasts a potential upside of 140.2% from the current RCKT share price of $22.62.

What is RCKT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: RCKT) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.